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Contribution of tenosynovitis of small joints to the symptom morning stiffness
in patients presenting with undifferentiated and rheumatoid arthritis
AC Boer1, DM Boeters1, E Niemantsverdriet1, AHM van der Helm-van Mil1,2
1Department of Rheumatology, Leiden University Medical Centre, Leiden, The Netherlands
2Department of Rheumatology, Erasmus Medical Centre, Rotterdam, The Netherlands
Objective: Morning stiffness (MS) is characteristic of rheumatoid arthritis (RA). Despite its association with
functional disability, the extent to which local inﬂammatory processes contribute to this symptom is unknown.
Magnetic resonance imaging (MRI)-detected tenosynovitis of small joints is recognized as an early feature of RA,
which is also associated with functional impairments. It has been proposed that tenosynovitis contributes to MS.
Therefore, we assessed the relationship between MS and MRI-detected inﬂammation, in particular tenosynovitis.
Method: In total, 286 consecutive patients newly presenting with undifferentiated arthritis and RA underwent
contrast-enhanced 1.5 T MRI of (2–5) metacarpophalangeal, wrist, and (1–5) metatarsophalangeal joints. Scans
were scored for tenosynovitis according to Haavardsholm, and for synovitis by Rheumatoid Arthritis Magnetic
Resonance Imaging Scoring (RAMRIS). MS was dichotomized as ≥ 60 min or not. Associations between MS and
tenosynovitis/synovitis were tested with logistic regression, data were categorized (solitary or simultaneous presence
of synovitis/tenosynovitis), and the presence of an additive interaction was assessed.
Results: MS was present in 40% of patients. Tenosynovitis was more often present in patients with MS than without
MS [80% vs 65%, odds ratio (OR) 2.11, 95% conﬁdence interval (1.21;3.69)]. Synovitis was more often present in
patients with MS [58% vs 44%, OR 1.79 (1.11;2.91)]. In categorized analyses, concurrent synovitis and tenosynovitis
had the largest association [OR 2.43 (1.30;4.54)], in contrast to solitary synovitis [OR 0.85 (0.21;3.47)]. The additive
interaction was non-signiﬁcant. The variance explained in all analyses was small (range 4–5%).
Conclusion: Tenosynovitis, combined with synovitis, at small joints is associated with MS and contributes to the
pathophysiology of MS.
Morning stiffness (MS) is characteristic of rheumatoid
arthritis (RA) and prevalent in 40–50% of patients (1).
MS has been a component of classiﬁcation and remission
criteria for RA, illustrating that it is considered a key symp-
tom. Its presence contributes to patients’ perceived disease
burden as it is consistently associated with functional dis-
ability (1–3). Although MS is prevalent and causes func-
tional limitations, its pathophysiology is still poorly
understood (1).
It is presumed that both systemic and local inﬂamma-
tion underlie MS (4). Most studies have focused on
systemic factors, which is intuitive as the circadian
rhythm of symptoms parallels late-night and early-
morning rises of pro-inﬂammatory markers (5). The
time relationship and the observation that MS could be
relieved by the application of low-dose prednisone dur-
ing the night makes it likely that systemic inﬂammatory
markers contribute to MS (6).
MS is generally most pronounced in the hands. It is not
known which structures are involved: joints or tendons.
However, in proportion to the number of studies focus-
ing on systemic markers, the association with local inﬂam-
mation is less well studied. An association with swollen
joints has been described (1), and some studies showed
correlations with ultrasound-detected synovitis (3, 7–9).
More recently, it has been shown that, next to syno-
vitis, tenosynovitis of small joints is characteristic of
RA. Tenosynovitis is associated with functional limita-
tions in patients with early inﬂammatory arthritis (10).
In this light, it has been suggested that tenosynovitis
contributes directly to MS (11). Some suggestive evi-
dence was obtained but analyses included small patient
populations, and other features of local inﬂammation,
such as concomitant synovitis, were not considered.
The fact that MS is a hallmark symptom of RA, but we
do not fully understand its pathophysiology, prompted us to
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perform this large cross-sectional magnetic resonance ima-
ging (MRI) study in which we aimed to determine whether
tenosynovitis, also in relation to synovitis, at small joints is
associated with MS in patients presenting with undifferen-
tiated arthritis (UA) and RA.
Method
Patient population
We studied cross-sectional data of 286 consecutive
patients from the Leiden Early Arthritis Clinic (EAC)
cohort included between June 2013 and February 2016.
The EAC is a population-based inception cohort of
patients with recent-onset arthritis and symptom dura-
tion < 2 years, as described previously (12). Patients,
diagnosed with RA (2010 or 1987 criteria) or UA (not
fulﬁlling these criteria, and no other diagnosis) who
underwent baseline gadolinium-enhanced MRI were
selected (Supplementary ﬁgure S1). The clinical diag-
nosis was made by the treating rheumatologist. RA was
further veriﬁed by the patient fulﬁlling the classiﬁcation
criteria during the ﬁrst year. Patients with missing MRI
scans were excluded (n = 65); they were not different
from included patients (Supplementary table S1).
Baseline questionnaires, swollen joint count including
66 joints (SJC66) and tender joint count including 68
joints (TJC68), and laboratory investigations were per-
formed. Written informed consent was obtained from all
patients. The study was approved by the local Medical
Ethics Committee Leiden (approval number P17.261).
MS measurements
Two questions on MS were answered. The ﬁrst concerned
the presence of MS (‘joints stiff in the morning: yes/no’)
and the second its duration (‘stiffness of the joints < 30min;
30–60 min; 1–2 h; 2–4 h; whole day’). Scores were
dichotomized for the presence (≥ 60 min) and absence of
MS (either ‘no’ or duration < 60 min), because this cut-off
has been shown to be sensitive and speciﬁc for RA (12). In
addition, we explored a cut-off of ≥ 30 min (12).
MRI scanning and scoring
Baseline 1.5 T MRI scans were performed (before the
initiation of any disease-modifying anti-rheumatic drugs),
of metacarpophalangeal (MCP 2–5), wrist, and metatarso-
phalangeal (MTP 1–5) joints of the more affected side (or
the dominant side in case of equal symptoms). Non-steroi-
dal anti-inﬂammatory drugs were stopped 24 h beforeMRI.
Scans were performed between 09:00 and 16:00 h and
scored in line with the Outcome Measures in Rheumatoid
Arthritis Clinical Trials (OMERACT)–Rheumatoid Arthri-
tis Magnetic Resonance Imaging Scoring (RAMRIS)
method by two independent readers; the mean scores of
both readers were calculated. Semi-quantitative scores ran-
ged from 0 to 3 per location and were summed for total
synovitis and tenosynovitis scores. MRI scans were con-
sidered positive for MRI-detected tenosynovitis/synovitis if
this was present in at least one joint, which was present in
< 5% of age-matched healthy controls (described in Sup-
plementary methods).
Statistics
Associations between MS and MRI-detected synovitis/
tenosynovitis were tested with logistic regression (MS
entered as the dependent variable, and clinical and imaging
ﬁndings as independent variables). The explained variance
was assessed by the Nagelkerke R2. As synovitis and teno-
synovitis often co-occur, to prevent collinearity, we did not
perform multivariable analyses but examined associations
of isolated and simultaneous presence of synovitis and
tenosynovitis by categorizing data. An additive interaction
Table 1. Baseline characteristics of rheumatoid arthritis and undifferentiated arthritis patients, and odds ratios with morning
stiffness (MS).
All patients
(n = 286)
MS present
(n = 113)
MS absent
(n = 173) OR (95% CI)
Age (years), mean ± sd 57 ± 16 56 ± 15 57 ± 15 0.99 (0.98;1.01)
Female, n (%) 178 (62) 65 (58) 113 (65) 1.39 (0.86;2.26)
SJC66, median (IQR) 3 (1–8) 6 (1–6) 2 (1–6) 1.08 (1.03;1.13)
Symptom duration (weeks), median (IQR) 10 (5–27) 9 (4–27) 11 (5–27) 1.00 (0.99;1.01)
CRP increased (≥ 5 mg/L), n (%) 165 (58) 76 (52) 89 (52) 1.95 (1.18;3.20)
RF positive (≥ 3.5 IU/mL), n (%) 104 (37) 47 (33) 57 (33) 1.36 (0.88;2.12)
ACPA positive (≥ 7 U/mL), n (%) 77 (27) 33 (26) 44 (26) 1.22 (0.72;2.08)
SJC66, swollen joint count including 66 joints; symptom duration: time since the start of any arthritis-related symptoms; CRP,
C-reactive protein (positive if ≥ 5 mg/L); RF, immunoglobulin M-rheumatoid factor (positive if ≥ 3.5 IU/mL); ACPA, anti-citrullinated
peptide antibody (anti-CCP2; EliA CCP, Phadia, the Netherlands; positive if ≥ 7 U/mL); sd, standard deviation; IQR, interquartile
range; CI, conﬁdence interval.
Positive associations with MS were found for CRP positivity; OR 1.95 indicates that patients with an increased CRP had a 1.95
higher odds of having MS than patients with a normal CRP; for SJC66, 1.08 means that per increase in swollen joint the patient had
a 1.08 higher odds of MS.
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was examined (13) by the relative risk excess (RERI),
synergy index (SI), and attributive proportion (AP). In the
absence of an interaction, RERI and AP equal 0, and SI
equals 1 (13), as described in Supplementary methods.
Sensitivity analyses were performed, ﬁrst in RA
patients (excluding UA patients) and secondly for MS
duration ≥ 30 min. Thirdly, as MS is often experienced
in the hands, MRI-detected inﬂammation was assessed
in the hand joints (excluding MTP joints).
IBM SPSS version 23 was used, and p values < 0.05
were considered signiﬁcant.
Results
Patient characteristics
Baseline characteristics are shown in Table 1. Forty
per cent of patients experienced MS. They had higher
SJC66 and CRP than those without MS (Table 1).
Associations between tenosynovitis and synovitis and MS
The median tenosynovitis score was 7 in patients with
and 3 in patients without MS (p = 0.001). The median
score for synovitis was 5 in patients with and 3 in
patients without MS (p = 0.001) (Figure 1A).
Tenosynovitis was present in 70%, and more often in
patients with MS [80% vs 65%; odds ratio (OR) 2.11,
95% conﬁdence interval (CI) (1.21;3.68)]. Synovitis
was present in 49%, and more often in patients with
MS [58% vs 44%; OR 1.79 (1.11;2.91)] (Table 2).
The explained variance (R2) ranged between 4 and
5% (Table 2).
Assessment of interaction of concurrent tenosynovitis
and synovitis in categorized data
Synovitis and tenosynovitis often occurred simultaneously:
combined synovitis and tenosynovitis was present in 127
patients (45%), solitary tenosynovitis in 72 (25%), solitary
synovitis in 12 (4%), and 71 (25%) patients had no syno-
vitis or tenosynovitis in the imaged joints. The presence of
simultaneous synovitis/tenosynovitis had the strongest
association with MS [OR 2.43 (1.30;4.54)], while synovitis
without tenosynovitis was not associated in categorized
analyses [OR 0.85 (0.21;3.47)] (Table 2, Figure 1B).
The presence of an additive interaction between
synovitis and tenosynovitis was explored; although the
Table 2. Associations of morning stiffness with presence of magnetic resonance imaging-detected tenosynovitis and synovitis, and
categorized analyses.
Presence of feature OR (95% CI) R2
Synovitis 1.79 (1.11;2.91) 0.04
Tenosynovitis 2.11 (1.21;3.68) 0.04
Categorized features
Synovitis Tenosynovitis OR (95% CI)
‒ ‒ 1.0 (ref.) 0.05
+ ‒ 0.85 (0.21;3.47)
‒ + 1.53 (0.76;3.09)
+ + 2.43 (1.30;4.54)
OR, odds ratio; CI, conﬁdence interval.
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Figure 1. (A) Association of morning stiffness (MS) with magnetic
resonance imaging-detected tenosynovitis and synovitis scores in
patients with and without MS: median [interquartile range (IQR)];
(B) evaluation of the additive effect of the combined presence of
synovitis and tenosynovitis. The relative risk excess (RERI) was
1.05 (‒0.52;2.62), attributive proportion (AP) 0.43 (‒0.18;1.05), and
synergy index (SI) 3.78 (0.05;270.0). OR: odds ratio.
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largest effect was obtained for concomitant synovitis/
tenosynovitis, the RERI was 1.05 (‒0.52;2.62), AP 0.43
(‒0.18;1.05), and SI 3.78 (0.05;270.0), suggesting
a small, non-signiﬁcant additive effect of combined
synovitis/tenosynovitis (Table 2, Figure 1B).
Sensitivity analyses
Analyses in RA patients (n = 168) (Supplementary table
S2) showed similar results for tenosynovitis and synovitis
with MS [OR 1.82 (0.75;4.42)] (Supplementary table S3).
Analyses of MS ≥ 30 min were also similar. The
simultaneous presence of tenosynovitis/synovitis was
associated with MS [OR 2.65 (1.45;4.84)] (Supplemen-
tary table S4 and S5).
Discussion
This cross-sectional study provided evidence for the rela-
tionship between MRI-detected tenosynovitis and MS in
RA and UA. The largest effect was obtained for simulta-
neous tenosynovitis/synovitis, while the solitary presence
of synovitis was not associated with MS. Importantly, all
effect sizes were relatively small and the proportion of
variance of MS explained by tenosynovitis was minor.
This suggests that local inﬂammation contributed to
a small extent, and implies that other factors may make
a greater contribution to the symptomatology of MS.
Most previous studies investigating associations
between inﬂammation and MS focused on systemic
inﬂammatory markers such as cytokines. Very few stu-
dies addressed the issue of local inﬂammation. One
study related MS to SJC (1), and a few to ultrasound-
detected synovitis (3, 7–9). Our results on SJC were
concordant with these studies (1, 2). For example, an
OR of 1.05 for MS with SJC was reported (1), which
was 1.08 here. To the best of our knowledge, this was
the ﬁrst study to examine the effect of MRI-detected
tenosynovitis in relation to MS, while also taking simul-
taneous presence of synovitis into account. The associa-
tion between MRI-detected inﬂammation and MS was
similar in RA and the total group.
Previous studies have shown that a duration of
MS > 60 min was speciﬁc for RA but > 30 min also
had good sensitivity and speciﬁcity (12). In our data,
ﬁndings were similar for both durations.
This study had some limitations. First, a uniformly
accepted deﬁnition of MS does not exist. We collected
data on MS duration but not on MS severity. Previous
reviews concluded that there is insufﬁcient evidence to
prioritize a measure for MS (4, 14). Whether the asso-
ciation of MRI-detected inﬂammation with MS severity
is stronger than that of MS presence is a subject for
further studies. Secondly, MRI scans were performed at
any time during the day. Ideally, they would have been
performed in the early morning, when MS is most
severe, but this was not feasible. Previous data showed
that MRI-detected inﬂammation does not change during
the day (15), but we cannot rule out that this has
resulted in underestimated effect sizes.
The biological mechanisms underlying MS are still
poorly understood. An association with local inﬂamma-
tion is presumable since (inﬁltrated) immune cells, and
also ﬁbroblast-like synoviocytes that are resident in the
joint at the synovium and in the surrounding synovial
compartment, follow the circadian rhythm. As synovitis
and tenosynovitis often occur simultaneously, we
hypothesized that this co-occurrence may contribute to
MS. Indeed, we observed the highest association for
simultaneous synovitis/tenosynovitis. However, we
found no additive interaction in relation to MS. Thus,
concomitant synovitis/tenosynovitis had the strongest
association with MS, without an additional effect.
Conclusion
The simultaneous presence of tenosynovitis and syno-
vitis was particularly associated with MS. However, the
effect sizes and percentages of the explained variance
suggested that the contribution of local inﬂammation to
this symptom, as detected by MRI, is rather limited.
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